Owing to its strengths in vaccine production, generic drugs, and biopharma, India life sciences industry is growing by leaps and bounds. Startups are playing a crucial role in its growth streak. Acknowledging this interesting development, we have put the spotlight on this segment in this special issue. The cover story of this issue features Enactis Healthcare, which is developing groundbreaking products for chronic care, primarily in preventive and supportive care in addition to therapeutics. The company's products have been developed with the intent of empowering the clinicians to optimize the treatment outcome and fill the existing gaps. The approach is in stark contrast to the usual run-of- the-mill production of brand after brand in the life sciences industry. In order to achieve the requisite quality, the company has stringent mechanisms in place. Since its inception, it has been able to ensure batch-wise standardization, which is one of the main challenges for startups.
Also featuring in this issue is Bangalore-based Bione, which is a company that has taken a leap with Asia's first DNA and microbiome testing kit. Bione uses DNA and gut analysis to detect the risk of chronic diseases like diabetes. Today, Bione is a B2C platform for genetic and microbiome testing. The issue also covers Unifaith Biotech which is a pharmaceutical organisation that delivers high quality critical care medicines across India. The company is involved in the marketing of tested and certified pharmaceutical drugs pan-India, meeting the demand for quality and affordability without any delay in supply.
After studying this market landscape in-depth, we have zeroed-in on the Top 10 startups that have excelled in this market with their innovative approach. Having proven their dedication to efficiency in order to meet the customer expectations in an end-to-end manner, these startups have stood-out from the crowd.
We look forward to receiving your feedback and suggestions.
We use cookies to ensure you get the best experience on our website. Read more...